These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 29183396)

  • 1. Indirect estimation of the prevalence of spinal muscular atrophy Type I, II, and III in the United States.
    Lally C; Jones C; Farwell W; Reyna SP; Cook SF; Flanders WD
    Orphanet J Rare Dis; 2017 Nov; 12(1):175. PubMed ID: 29183396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spinal muscular atrophy: survival pattern and functional status.
    Chung BH; Wong VC; Ip P
    Pediatrics; 2004 Nov; 114(5):e548-53. PubMed ID: 15492357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An overview of the Cure SMA membership database: Highlights of key demographic and clinical characteristics of SMA members.
    Belter L; Cook SF; Crawford TO; Jarecki J; Jones CC; Kissel JT; Schroth M; Hobby K
    J Neuromuscul Dis; 2018; 5(2):167-176. PubMed ID: 29614694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Observations from a nationwide vigilance program in medical care for spinal muscular atrophy patients in Chile.
    Alvarez K; Suarez B; Palomino MA; Hervias C; Calcagno G; Martínez-Jalilie M; Lozano-Arango A; Lillo S; Haro M; Cortés F; Pantoja S; Chahin A; Orellana P; Bevilacqua JA; Bertini E; Castiglioni C
    Arq Neuropsiquiatr; 2019 Jul; 77(7):470-477. PubMed ID: 31365638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The predictive value of achieved motor milestones assessed in 441 patients with infantile spinal muscular atrophy types II and III.
    Rudnik-Schöneborn S; Hausmanowa-Petrusewicz I; Borkowska J; Zerres K
    Eur Neurol; 2001; 45(3):174-81. PubMed ID: 11306862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic Literature Review to Assess the Cost and Resource Use Associated with Spinal Muscular Atrophy Management.
    Paracha N; Hudson P; Mitchell S; Sutherland CS
    Pharmacoeconomics; 2022 Apr; 40(Suppl 1):11-38. PubMed ID: 34761360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The changing natural history of spinal muscular atrophy type 1.
    Oskoui M; Levy G; Garland CJ; Gray JM; O'Hagen J; De Vivo DC; Kaufmann P
    Neurology; 2007 Nov; 69(20):1931-6. PubMed ID: 17998484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical study of 83 cases with spinal muscular atrophy in children].
    Li H; Wang HL; Shan CM
    Zhonghua Er Ke Za Zhi; 2004 Oct; 42(10):762-4. PubMed ID: 16221347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vital capacity in spinal muscular atrophy.
    Bach JR; Tuccio MC; Khan U; Saporito LR
    Am J Phys Med Rehabil; 2012 Jun; 91(6):487-93. PubMed ID: 22469873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population-based analysis of survival in spinal muscular atrophy.
    Wijngaarde CA; Stam M; Otto LAM; van Eijk RPA; Cuppen I; Veldhoen ES; van den Berg LH; Wadman RI; van der Pol WL
    Neurology; 2020 Apr; 94(15):e1634-e1644. PubMed ID: 32217777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics of three subtypes of spinal muscular atrophy in children.
    Yuan P; Jiang L
    Brain Dev; 2015 May; 37(5):537-41. PubMed ID: 25199871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Respiratory capacity course in patients with infantile spinal muscular atrophy.
    Ioos C; Leclair-Richard D; Mrad S; Barois A; Estournet-Mathiaud B
    Chest; 2004 Sep; 126(3):831-7. PubMed ID: 15364763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early infantile form of spinal muscular atrophy (Werdnig-Hoffmann disease) with prolonged survival.
    Borkowska J; Rudnik-Schoneborn S; Hausmanowa-Petrusewicz I; Zerres K
    Folia Neuropathol; 2002; 40(1):19-26. PubMed ID: 12121035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing perspectives of disease burden and clinically meaningful changes using the Spinal Muscular Atrophy Health Index in adolescents and young adults.
    Mazzella A; Cruz R; Belter L; Curry M; Dilek N; Zizzi C; Heatwole C; Jarecki J
    Muscle Nerve; 2022 Sep; 66(3):276-281. PubMed ID: 35616549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival probabilities of patients with childhood spinal muscle atrophy.
    Mannaa MM; Kalra M; Wong B; Cohen AP; Amin RS
    J Clin Neuromuscul Dis; 2009 Mar; 10(3):85-9. PubMed ID: 19258855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of type I spinal muscular atrophy in North Dakota.
    Burd L; Short SK; Martsolf JT; Nelson RA
    Am J Med Genet; 1991 Nov; 41(2):212-5. PubMed ID: 1785637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Very severe spinal muscular atrophy (SMA type 0): an expanding clinical phenotype.
    Dubowitz V
    Eur J Paediatr Neurol; 1999; 3(2):49-51. PubMed ID: 10700538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotype-phenotype studies in infantile spinal muscular atrophy (SMA) type I in Germany: implications for clinical trials and genetic counselling.
    Rudnik-Schöneborn S; Berg C; Zerres K; Betzler C; Grimm T; Eggermann T; Eggermann K; Wirth R; Wirth B; Heller R
    Clin Genet; 2009 Aug; 76(2):168-78. PubMed ID: 19780763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenusinersen economic and health-related quality of life burden of spinal muscular atrophy.
    Chambers GM; Settumba SN; Carey KA; Cairns A; Menezes MP; Ryan M; Farrar MA
    Neurology; 2020 Jul; 95(1):e1-e10. PubMed ID: 32513788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular genetic diagnosis and deletion analysis in Type I-III spinal muscular atrophy].
    Spiegel R; Hagmann A; Boltshauser E; Moser H
    Schweiz Med Wochenschr; 1996 May; 126(21):907-14. PubMed ID: 8693311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.